BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35214160)

  • 1. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
    García-Molina P; Sola-Leyva A; Luque-Navarro PM; Laso A; Ríos-Marco P; Ríos A; Lanari D; Torretta A; Parisini E; López-Cara LC; Marco C; Carrasco-Jiménez MP
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy.
    Inazu M; Yamada T; Kubota N; Yamanaka T
    Pharmacol Res; 2013 Oct; 76():119-31. PubMed ID: 23948665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
    Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
    PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy.
    Jabalera Y; Sola-Leyva A; Peigneux A; Vurro F; Iglesias GR; Vilchez-Garcia J; Pérez-Prieto I; Aguilar-Troyano FJ; López-Cara LC; Carrasco-Jiménez MP; Jimenez-Lopez C
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31408964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer.
    Mariotto E; Viola G; Ronca R; Persano L; Aveic S; Bhujwalla ZM; Mori N; Accordi B; Serafin V; López-Cara LC; Bortolozzi R
    Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30360374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.
    Nagashima F; Nishiyama R; Iwao B; Kawai Y; Ishii C; Yamanaka T; Uchino H; Inazu M
    Biomol Ther (Seoul); 2018 Jul; 26(4):399-408. PubMed ID: 29223141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
    Schiaffino-Ortega S; Baglioni E; Mariotto E; Bortolozzi R; Serrán-Aguilera L; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Hurtado-Guerrero R; Marco C; Basso G; Viola G; Entrena A; López-Cara LC
    Sci Rep; 2016 Mar; 6():23793. PubMed ID: 27029499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells.
    Hirai K; Watanabe S; Nishijima N; Shibata K; Hase A; Yamanaka T; Inazu M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.
    Gallego-Ortega D; Gómez del Pulgar T; Valdés-Mora F; Cebrián A; Lacal JC
    Adv Enzyme Regul; 2011; 51(1):183-94. PubMed ID: 21035492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells.
    Watanabe S; Nishijima N; Hirai K; Shibata K; Hase A; Yamanaka T; Inazu M
    Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32466342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Expression of Choline Transporter-Like Protein 1 in LNCaP Prostate Cancer Cells: A Novel Molecular Target.
    Saiki I; Yara M; Yamanaka T; Uchino H; Inazu M
    Biomol Ther (Seoul); 2020 Mar; 28(2):195-201. PubMed ID: 31693854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake.
    Nakamura T; Fujiwara R; Ishiguro N; Oyabu M; Nakanishi T; Shirasaka Y; Maeda T; Tamai I
    Biol Pharm Bull; 2010; 33(4):691-6. PubMed ID: 20410607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C promotes choline transporter‑like protein 1 function via improved cell surface expression in immortalized human hepatic cells.
    Ishikawa T; Suwanai H; Shikuma J; Suzuki R; Yamanaka T; Odawara M; Inazu M
    Mol Med Rep; 2020 Feb; 21(2):777-785. PubMed ID: 31974614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choline kinase inhibitor hemicholinium-3 can inhibit mitogen-induced DNA synthesis independent of its effect on phosphocholine formation.
    Crilly KS; Tomono M; Kiss Z
    Arch Biochem Biophys; 1998 Apr; 352(1):137-43. PubMed ID: 9521826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells.
    Kouji H; Inazu M; Yamada T; Tajima H; Aoki T; Matsumiya T
    Arch Biochem Biophys; 2009 Mar; 483(1):90-8. PubMed ID: 19135976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism.
    Gobeil Odai K; O'Dwyer C; Steenbergen R; Shaw TA; Renner TM; Ghorbani P; Rezaaifar M; Han S; Langlois MA; Crawley AM; Russell RS; Pezacki JP; Tyrrell DL; Fullerton MD
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline transport links macrophage phospholipid metabolism and inflammation.
    Snider SA; Margison KD; Ghorbani P; LeBlond ND; O'Dwyer C; Nunes JRC; Nguyen T; Xu H; Bennett SAL; Fullerton MD
    J Biol Chem; 2018 Jul; 293(29):11600-11611. PubMed ID: 29880645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of choline transporter in tongue cancer: A novel molecular target for tongue cancer therapy.
    Nishiyama R; Nagashima F; Iwao B; Kawai Y; Inoue K; Midori A; Yamanaka T; Uchino H; Inazu M
    J Pharmacol Sci; 2016 Jun; 131(2):101-9. PubMed ID: 27262903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
    Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
    NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.
    Inazu M
    Biopharm Drug Dispos; 2014 Nov; 35(8):431-49. PubMed ID: 24532461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.